Mackenzie Financial »

Fulcrum Therapeutics shares owned by Mackenzie Financial

Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by Mackenzie Financial from 13F filings

Historical chart of Mackenzie Financial investment in Fulcrum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fulcrum Therapeutics held by Mackenzie Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fulcrum Therapeutics by Mackenzie Financial

Quarter filed Position value Share count Share price at filing
2024-12-31 $555k 118k 4.70
2024-09-30 $82k 23k 3.57

More positions owned by Mackenzie Financial

Royal Bank of Canada Common Stock (RY)
Rbc Cad (RY)
Microsoft Corp Common Stock (MSFT)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (Principal) (SPY)
Apple Common Stock (AAPL)
Apple (AAPL)
NVIDIA Corporation (NVDA)
SPDR S&P 500 ETF Trust Etp (SPY)
Stantec (STN)
Toronto-Dominion Bank/The Common Stock (TD)
Toronto Dominion Bk Ont Com New (TD)
Amazon.com Common Stock (AMZN)
Amazon (AMZN)
Thomson Reuters Corp. (TRI)

View all positions for Mackenzie Financial

Top funds holding Fulcrum Therapeutics

RA Capital Management
TCG Crossover Management
BlackRock
Nantahala Capital Management
Suvretta Capital Management
Vanguard Group
Adage Capital Partners GP
Morgan Stanley
Dimensional Fund Advisors
Woodline Partners
Geode Capital Management
State Street Corporation
Northern Trust
D. E. Shaw & Co
Goldman Sachs Group

View all funds holding Fulcrum Therapeutics